Disclosure and sources of funding

The project has been funded nearly exclusively by competed research funds. The major supporters (>95% of all funding) have been the Helsinki University Research Funds, the Academy of Finland, the Cancer Society of Finland, and the Yamanouchi European Foundation. The Finish Breast Cancer Group has also supported the project financially. These financial contributors are warmly acknowledged.